Morgan Stanley
LRGE icon

Morgan Stanley’s ClearBridge Large Cap Growth Select ETF LRGE Stock Holding History

Morgan Stanley’s Portfolio LRGE Stock Details LRGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.6M Sell
353,143
-3,912
-1% -$311K ﹤0.01% 2678
2025
Q4 		$29.4M Sell
357,055
-6,165
-2% -$512K ﹤0.01% 2585
2025
Q3 		$30.3M Sell
363,220
-10,566
-3% -$850K ﹤0.01% 2474
2025
Q2 		$29.6M Sell
373,786
-36,087
-9% -$2.63M ﹤0.01% 2423
2025
Q1 		$28.6M Sell
409,873
-8,426
-2% -$632K ﹤0.01% 2325
2024
Q4 		$31.5M Sell
418,299
-35,519
-8% -$2.69M ﹤0.01% 2287
2024
Q3 		$33.1M Sell
453,818
-23,425
-5% -$1.65M ﹤0.01% 2266
2024
Q2 		$33.3M Buy
477,243
+205,162
+75% +$13.7M ﹤0.01% 2143
2024
Q1 		$18.3M Sell
272,081
-189,971
-41% -$12.2M ﹤0.01% 2797
2023
Q4 		$27.6M Buy
462,052
+235,403
+104% +$13M ﹤0.01% 3062
2023
Q3 		$11.7M Buy
226,649
+6,253
+3% +$338K ﹤0.01% 2974
2023
Q2 		$12M Sell
220,396
-17,584
-7% -$875K ﹤0.01% 3001
2023
Q1 		$11.3M Sell
237,980
-59,024
-20% -$2.64M ﹤0.01% 3036
2022
Q4 		$12.1M Sell
297,004
-157,707
-35% -$6.61M ﹤0.01% 2888
2022
Q3 		$18M Buy
454,711
+172,763
+61% +$7.69M ﹤0.01% 2301
2022
Q2 		$11.8M Sell
281,948
-53,417
-16% -$2.45M ﹤0.01% 2902
2022
Q1 		$18M Sell
335,365
-14,325
-4% -$766K ﹤0.01% 2230
2021
Q4 		$21.2M Sell
349,690
-808
-0.2% -$48.7K ﹤0.01% 2083
2021
Q3 		$19.8M Sell
350,498
-7,625
-2% -$439K ﹤0.01% 2094
2021
Q2 		$20M Buy
358,123
+19,712
+6% +$1.05M ﹤0.01% 2143
2021
Q1 		$17.1M Buy
338,411
+27,066
+9% +$1.35M ﹤0.01% 2084
2020
Q4 		$15.6M Buy
311,345
+69,287
+29% +$3.32M ﹤0.01% 2058
2020
Q3 		$11.1M Buy
242,058
+39,470
+19% +$1.75M ﹤0.01% 1938
2020
Q2 		$8.27M Sell
202,588
-29,146
-13% -$1.1M ﹤0.01% 2144
2020
Q1 		$7.51M Buy
231,734
+69,827
+43% +$2.58M ﹤0.01% 2049
2019
Q4 		$6.16M Buy
161,907
+130,944
+423% +$4.76M ﹤0.01% 2958
2019
Q3 		$1.08M Buy
+30,963
New +$1.09M ﹤0.01% 4251

Other funds holding LRGE

OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
M&T Bank
M&T Bank Buffalo, New York $29.2B AUM 22.81% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Morgan Stanley's LRGE Position: Q1 2026 in Review

Morgan Stanley reduced its ClearBridge Large Cap Growth Select ETF (LRGE) stake by 1.1% in Q1 2026, selling an estimated $311K and leaving 353,143 shares worth $26.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

Morgan Stanley first reported a position in LRGE in Q3 2019 and has held it in 27 quarters since. The position peaked at $33.3M in Q2 2024. 82 funds tracked by Wall St. Rank hold LRGE as of Q1 2026.

  • Morgan Stanley held 353,143 shares of ClearBridge Large Cap Growth Select ETF worth $26.6M as of Q1 2026.
  • Morgan Stanley sold 3,912 ClearBridge Large Cap Growth Select ETF shares in Q1 2026, an estimated $311K.
  • ClearBridge Large Cap Growth Select ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2678 holding.
  • Morgan Stanley first reported a position in ClearBridge Large Cap Growth Select ETF in Q3 2019 and has held it in 27 quarters since.
  • Morgan Stanley's ClearBridge Large Cap Growth Select ETF position peaked at $33.3M in Q2 2024.
  • 82 funds tracked by Wall St. Rank held ClearBridge Large Cap Growth Select ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.